🇺🇸 FDA
Patent

US 9371352

Modified glycolipids and methods of making and using the same

granted A61KA61K2039/505A61K2039/55572

Quick answer

US patent 9371352 (Modified glycolipids and methods of making and using the same) held by VACCINEX, INC. expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VACCINEX, INC.
Grant date
Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K2039/505, A61K2039/55572, A61K2039/572, A61K2039/575